West Announces First Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
West Pharma (WST) Tops Q1 EPS by 5c
April 30, 2015 7:09 AM EDTWest Pharma (NYSE: WST) reported Q1 EPS of $0.45, $0.05 better than the analyst estimate of $0.40. Revenue for the quarter came in at $335.9 million, or $369.4 constant currency, versus the consensus estimate of $346.64 million.
West Pharma sees FY2015 EPS of $1.69-$1.84, versus the consensus of $1.84.
"West had a very good start to 2015 despite the challenge presented by the strengthening U.S. dollar," said Donald E. Morel Jr., PhD, West's Chairman. "The keys to our performance were the particularly strong growth in high-value packaging component sales, which had declined in the 2014 quarter, and managing our... More
